Karlis Pauksens
Uppsala, C, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Chronic norovirus infection in a patient with Good's syndrome resolved after fecal microbiota transplantion and improved nutrional status.
Journal: Infectious diseases (London, England)
Published: February 13, 2026
Disseminated Ureaplasma infection: a case report of a patient with rheumatoid arthritis on rituximab therapy with multiple abscesses and arthritis.
Journal: Upsala journal of medical sciences
Published: December 04, 2025
A human pan-disease blood atlas of the circulating proteome.
Journal: Science (New York, N.Y.)
Published: October 09, 2025
Management of cytomegalovirus infections - Swedish recommendations 2023.
Journal: Infectious diseases (London, England)
Published: August 26, 2024
A third dose SARS‑CoV‑2 BNT162b2 mRNA vaccine results in improved immune response in hemodialysis patients.
Journal: Upsala journal of medical sciences
Published: August 10, 2022
Relationship between T-cell-dependent and T-cell-independent vaccines after neurotrauma; is the B-cell response preserved?
Journal: Human vaccines & immunotherapeutics
Published: June 15, 2022
Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 01, 2022
Humoral and cellular response to SARS-CoV-2 BNT162b2 mRNA vaccine in hemodialysis patients.
Journal: BMC immunology
Published: August 19, 2021
High expression of neutrophil and monocyte CD64 with simultaneous lack of upregulation of adhesion receptors CD11b, CD162, CD15, CD65 on neutrophils in severe COVID-19.
Journal: Therapeutic advances in infectious disease
Published: May 25, 2021
Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders.
Journal: Acta oncologica (Stockholm, Sweden)
Published: April 01, 2021
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 31, 2021
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial.
Journal: Trials
Published: February 15, 2021
Last Updated: 09/26/2026